>

Orphazyme Stock Price Prediction

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:4em;padding-top: 25px;;'>OR</div>
ORPHA -- Denmark Stock  

DKK 90.80  0.10  0.11%

We analyze noise-free headlines and recent hype associated with Orphazyme AS, which may create opportunities for some arbitrage if properly timed. Please check Orphazyme Basic Forecasting Models to cross-verify your projections.
View Stock Price Prediction For
Refresh
The Orphazyme stock price prediction module also provides an analysis of price elasticity to changes in media outlook on Orphazyme over a specific investment horizon. Using Orphazyme hype-based prediction, you can estimate the value of Orphazyme AS from the perspective of Orphazyme response to recently generated media hype and the effects of current headlines on its competitors.

Orphazyme After-Hype Price Density Analysis

 Next price density 
    
  Expected price to next headline 

Orphazyme Estimiated After-Hype Price Volatility

Current Value
90.80
6th of April 2020
90.80
After-hype Price
110.06
Upside
Orphazyme is not too volatile asset. Analysis and calculation of next after-hype price of Orphazyme AS is based on 3 months time horizon.

Orphazyme Stock Price Prediction Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.30  6.42  0.00   0.00  0 Events / Month0 Events / MonthUncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
90.8090.800.00 
0.00  

Orphazyme Hype Timeline

Orphazyme AS is now traded for 90.80on Copenhagen Stock Exchange of Denmark. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Orphazyme AS is anticipated not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 0.0%. The immediate return on the next news is anticipated to be very small where as daily expected return is now at 0.3%. The volatility of relative hype elasticity to Orphazyme is about 0.0%%. The volatility of related hype on Orphazyme is about 0.0% with expected price after next announcement by competition of 90.8. The company recorded loss per share of 16.87. Orphazyme AS had not issued any dividends in recent years. Assuming 30 trading days horizon, the next anticipated press release will be uncertain.
Please check Orphazyme Basic Forecasting Models to cross-verify your projections.

Orphazyme Related Hype Analysis

Please check Orphazyme Basic Forecasting Models to cross-verify your projections. Please also try Idea Breakdown module to analyze constituents of all macroaxis ideas. macroaxis investment ideas are predefined, sector-focused investing themes.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page